NVUS - Novus up 15% on advancement of OP0201 January, 31 2019 10:32 AM Novus Therapeutics Inc. Thinly traded nano cap Novus Therapeutics (NVUS +14.9%) is up on average volume following its updates on clinical trials supporting lead drug OP0201. More news on: Novus Therapeutics, Healthcare stocks news, Stocks on the move, Read more ...